Xavier Champavere
Vorstandsvorsitzender bei Arvem SAS
Aktive Positionen von Xavier Champavere
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Arvem SAS
Arvem SAS Advertising/Marketing ServicesCommercial Services Arvem SAS operates as an advertising agency. The company was founded on November 23, 1999 and is headquartered in Paris, France. | Vorstandsvorsitzender | 15.07.2011 | - |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Xavier Champavere
Statistik
International
Frankreich | 2 |
Singapur | 2 |
Operativ
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Arvem SAS
Arvem SAS Advertising/Marketing ServicesCommercial Services Arvem SAS operates as an advertising agency. The company was founded on November 23, 1999 and is headquartered in Paris, France. | Commercial Services |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Health Technology |
- Börse
- Insiders
- Xavier Champavere
- Erfahrung